720-777-0123
- Your Visit
-
Research & Innovation
It starts with a Q:
For the latest cutting-edge research, innovative collaborations and remarkable discoveries in child health, read stories from across all our areas of study in Q: Advances and Answers in Pediatric Health.
Paul Wadwa, MD
Get to know Paul Wadwa, MD
- Juvenile Diabetes
- English
Type 1 Diabetes, Clinical trials in type 1 diabetes, Telemedicine, artificial pancreas technology
Undergraduate 1992
Northwestern University (IL)
Medical Education 1996
Northwestern University The Feinberg School of Medicine
Internship 1997
Nationwide Children's Hospital/Ohio State University Program
Residency 2000
Nationwide Children's Hospital/Ohio State University Program
Fellowship 2003
Cincinnati Children's Hospital Medical Center Program
For Patients:
My primary research focus is on the development of the artificial pancreas for patients with type 1 diabetes. I am involved in many clinical research studies with the goal of advancing artificial pancreas technology. I am also engaged in clinical trials of new therapeutic agents as well as research describing the effects of a clinical telemedicine program on diabetes control for youth with type 1 diabetes. My hope is that the research I am involved with will greatly improve the tools available to optimize control and reduce the burden of diabetes for patients locally and beyond.
My primary research focus is on the development of the artificial pancreas for patients with type 1 diabetes. I am involved in many clinical research studies with the goal of advancing artificial pancreas technology. I am also engaged in clinical trials of new therapeutic agents as well as research describing the effects of a clinical telemedicine program on diabetes control for youth with type 1 diabetes. My hope is that the research I am involved with will greatly improve the tools available to optimize control and reduce the burden of diabetes for patients locally and beyond.
For Referring Providers:
Dr. Wadwa’s research primarily focuses on the development of the artificial pancreas. He is engaged as a site PI and as a co-investigator for several NIH-sponsored and industry- sponsored clinical research studies with the goal of advancing artificial pancreas technology. Dr. Wadwa is also engaged in clinical trials of new therapeutic agents as well as research describing the effects of a clinical telemedicine program on glycemic control in pediatric type 1 diabetes patients.
Dr. Wadwa’s research primarily focuses on the development of the artificial pancreas. He is engaged as a site PI and as a co-investigator for several NIH-sponsored and industry- sponsored clinical research studies with the goal of advancing artificial pancreas technology. Dr. Wadwa is also engaged in clinical trials of new therapeutic agents as well as research describing the effects of a clinical telemedicine program on glycemic control in pediatric type 1 diabetes patients.
O'Brien Fellowship Award 2015
Children's Diabetes Foundation/ Barbara Davis Center
